Morgan Stanley Knock-Out SSNHZ/ DE000ME127F1 /
29/07/2024 11:31:24 | Chg.+0.01 | Bid11:45:22 | Ask11:45:22 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
8.15EUR | +0.12% | 8.18 Bid Size: 1,000 |
8.23 Ask Size: 1,000 |
Samsung Electronics ... | 584.8279 - | 31/12/2078 | Call |
GlobeNewswire
01/07
FDA Approves PYZCHIVA® (ustekinumab-ttwe), Samsung Bioepis’ Biosimilar to Stelara
GlobeNewswire
26/06
Primarius NanoSpice™ Simulator Certified for Samsung Foundry 3nm/4nm Process Technology
GlobeNewswire
25/06
Pixalate Releases Top 100 Connected TV (CTV) Bundle ID Rankings For Global Open Programmatic Ad Spen...
GlobeNewswire
25/06
Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D ...
GlobeNewswire
14/06
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
15/05
Pixalate’s April 2024 Top Grossing Connected TV (CTV) Apps Based on Global Open Programmatic Ad Reve...
GlobeNewswire
09/05
Pixalate Releases Top 100 Connected TV (CTV) Bundle ID Rankings For Global Open Programmatic Adverti...
GlobeNewswire
02/05
Pixalate Releases LATAM Q1 2024 Connected TV (CTV) Device Market Share Report: Roku Leads with 39% M...